POCT Chemiluminescence System

A POCT-series chemiluminescence immunoassay analyzer designed for point-of-care diagnostic testing. This instrument is part of B&C Biological's POCT product line for rapid immunodiagnostic applications in clinical settings.

An automated analyzer for point-of-care testing (POCT) that performs chemiluminescence immunoassays. The device is designed for immunological testing applications and is part of the company's in vitro diagnostic automation product portfolio.

A proprietary dry-phase photoactivated chemiluminescence technology platform for point-of-care testing. Covers cardiovascular, inflammatory, tumor marker, hormone, and infectious disease diagnostics.

Portable chemiluminescence immunoassay analyzer (POCT CLIA) for point-of-care diagnostics. The Lumilite 8 system delivers core laboratory precision with compact design, enabling rapid immunoassay testing in clinical settings. Supports single-test and multiplex assay protocols for streamlined diagnostic workflows.

A chemiluminescence-based immunoassay system for laboratory diagnostics. It utilizes chemiluminescence technology to detect and measure specific analytes in patient samples for various clinical applications.

Chemiluminescence diagnostic platform for quantitative and qualitative analysis of biomarkers in patient samples. Delivers sensitive detection capabilities for clinical laboratory and point-of-care applications.

A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.

A diagnostic platform featuring high sensitivity and wide detection menu that comprehensively covers critical care, cardiovascular and cerebrovascular diseases, and other key clinical areas. The platform is widely applied in clinical departments such as laboratory medicine, emergency medicine, and ICU, while also suitable for diverse scenarios including primary healthcare facilities, health examination centers, and reproductive centers.

High-sensitivity diagnostic reagents utilizing chemiluminescence technology for CLIA diagnostics, providing conclusive results in modern laboratory settings.

In vitro diagnostic reagent kit for chemiluminescence-based immunoassays. Used for quantitative measurement of various analytes in patient samples for clinical diagnosis.

POCT Chronic Disease Monitoring Systems enable rapid point-of-care testing for chronic disease management through colloidal gold and chemiluminescence immunoassay technologies. The platform supports multiple diagnostic test series including cardiac markers, biochemical parameters, and disease monitoring. Designed for clinical laboratories and healthcare facilities requiring quick, quantitative diagnostic results.